Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
with a second cycle academic degree (MSc, MD or equivalent) in biology, biochemistry, bioinformatics, biotechnology, cell biology, computer science, genetics, medicine, or other related fields, obtained
-
-Holstein (UKSH), is seeking a PhD student with a strong background in statistics, machine learning (ML)/artificial intelligence (AI), or bioinformatics. Our group develops novel computational and statistical
-
well as basic research with the combined tools of immunology, microbiology, virology, cell biology and molecular biology. For more information, please see https://www.mhh.de/hbrs/zib MD/PhD Molecular Medicine:The
-
from chem- and bioinformatics to computer vision and social network analysis. Machine learning with graphs aims at exploiting the potential of the growing amount of structured data in all these areas
-
Cancer Centre in Toronto, Canada. All research groups are internationally leading experts in immunology, cancer, and bioinformatics. The project aims to explore how antiviral defense pathways can be
-
can be used as a therapeutic target to treat human diseases. In this context, one key methodology that we are using is constraint-based metabolic modelling approaches. Start in our team: We are looking
-
LMU Munich. The group is located within the Institute of Clinical Neuroimmunology (https://www.neuroimmunology-munich.de/ ). The professorship of Systems Neuroimmunology is part of the Cluster
-
regulations. Further information on data protection and the processing of personal data can be found at: https://www.isas.de/en/datenschutz . The closing date for applications is April 11, 2026. Please apply
-
and in silico. We focus on neurodegenerative processes and are especially interested in Alzheimer's and Parkinson's disease and their contributing factors. The LCSB recruits talented scientists from
-
of this process, alterations in RNP granules have been linked to ALS pathogenesis and MN degeneration. Thus, a better understanding of RNP granules could lead to novel therapeutics to protect MN axons against